our mission
The FAEP’s mission is to support the professional development of its members and to educate its members on conditions affecting the equine industry as well as methods for improving the welfare of horses in the state of Florida.

Join Our Email List
Email:  

paid advertisement

paid advertisement
upcoming events

Recurring Monthly
Podiatry Clinic
The Sanctuary
Ocala, FL
Download the flyer

Oct. 11 - 14, 2012
FAEP 8th Promoting Excellence Symposium In the Southeast
Naples, FL

Coming in Fall 2012
Ocala, FL
50th Annual Equine Conference

Nationwide voluntary ketamine recall by Teva Animal Health

January 4, 2010

The following information is posted on the AVMA Web site at http://www.avma.org/news/ketamine.asp and will be updated as necessary. The statement below contains updates based on information received from the FDA, Fort Dodge/Pfizer, and Teva Animal Health on January 4, 2010.

On December 22, 2009, the U.S. Food and Drug Administration (FDA) announced a nationwide voluntary recall of ketamine hydrochloride injetable (100mg/ml, 10 ml vials) manufactured by Teva Animal Health, Inc. Not all Teva products are affected by the recall. Teva Animal Health also manufactures ketamine hydrochloride products for other companies. These products are sold under various brand names and can include the following:

Teva Animal Health does not distribute products internationally.

Teva Animal Health is not the only manufacturer of ketamine hydrochloride in the U.S. and not all products sold under the above-listed names listed are affected. Therefore, regardless of the brand name on the product, look at the lot number on all ketamine hydrochloride (100 mg/ml in 10 ml vials) products.

For additional information and ongoing updates, please bookmark http://www.avma.org/news/ketamine.asp and check back there regularly. They also are posting important updates to their Twitter feed.

Back to main news page